These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1694008)

  • 41. Friend virus-induced erythroleukemia and the multistage nature of cancer.
    Ben-David Y; Bernstein A
    Cell; 1991 Sep; 66(5):831-4. PubMed ID: 1889087
    [No Abstract]   [Full Text] [Related]  

  • 42. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
    Slingerland JM; Jenkins JR; Benchimol S
    EMBO J; 1993 Mar; 12(3):1029-37. PubMed ID: 8458321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
    Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
    Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome.
    Sitbon M; Sola B; Evans L; Nishio J; Hayes SF; Nathanson K; Garon CF; Chesebro B
    Cell; 1986 Dec; 47(6):851-9. PubMed ID: 3465451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming activity of mutant human p53 alleles.
    Slingerland JM; Benchimol S
    J Cell Physiol; 1991 Sep; 148(3):391-5. PubMed ID: 1918170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Finlay CA; Hinds PW; Tan TH; Eliyahu D; Oren M; Levine AJ
    Mol Cell Biol; 1988 Feb; 8(2):531-9. PubMed ID: 2832726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides.
    Li Y; Golemis E; Hartley JW; Hopkins N
    J Virol; 1987 Mar; 61(3):693-700. PubMed ID: 3468264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular cloning of Friend mink cell focus-inducing virus: identification of mink cell focus-inducing virus-like messages in normal and transformed cells.
    Oliff A; Collins L; Mirenda C
    J Virol; 1983 Nov; 48(2):542-6. PubMed ID: 6312107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses.
    Oliff A; Signorelli K; Collins L
    J Virol; 1984 Sep; 51(3):788-94. PubMed ID: 6088801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.
    Wolf D; Rotter V
    Mol Cell Biol; 1984 Jul; 4(7):1402-10. PubMed ID: 6095069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anemia- and polycythemia-inducing isolates of Friend spleen focus-forming virus. Biological and molecular evidence for two distinct viral genomes.
    MacDonald ME; Reynolds FH; Van de Ven WJ; Stephenson JR; Mak TW; Bernstein A
    J Exp Med; 1980 Jun; 151(6):1477-92. PubMed ID: 6929880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A unique sequence related to the ecotropic murine leukemia virus is associated with the Fv-4 resistance gene.
    Kozak CA; Gromet NJ; Ikeda H; Buckler CE
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):834-7. PubMed ID: 6322171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of BALB/c mice carrying various DBA/2 genes to development of Friend murine leukemia virus-induced erythroleukemia.
    Ruscetti S; Matthai R; Potter M
    J Exp Med; 1985 Nov; 162(5):1579-87. PubMed ID: 3863879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
    Bartek J; Iggo R; Gannon J; Lane DP
    Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mouse DDA3 gene is a direct transcriptional target of p53 and p73.
    Hsieh SC; Lo PK; Wang FF
    Oncogene; 2002 May; 21(19):3050-7. PubMed ID: 12082536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.
    Paul R; Schuetze S; Kozak SL; Kabat D
    J Virol; 1989 Nov; 63(11):4958-61. PubMed ID: 2552176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.